Skip to content

Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy

Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002695
Enrollment
56
Registered
2018-02-14
Start date
2017-05-04
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(cosmetics) : To prevent and care supportively the skin reaction after radiotherapy for breast cancer, patients should apply the moisturizer 3 times a day from starting day to 1 month after fini

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: nonprobability sampling method - convenience sampling a. breast cancer b. patients who were referred to adjuvant radiation therapy c. age with 20 ~ 60 yo d. informed consent should be obtained after understanding of the purpose of this study

Exclusion criteria

Exclusion criteria: a. former radiation therapy b. skin metastasis c. skin ulceration d. impossible to follow up according to protocol

Design outcomes

Primary

MeasureTime frame
erythema (mexameter) & skin hydration (corneometer)

Secondary

MeasureTime frame
Questionnaire including skin dryness, itchiness, burning sensation, pain

Countries

Korea, Republic of

Contacts

Public ContactKiHoon Sung

Gachon University Gil Medical Center

novalis@gilhospital.com+82-32-460-8052

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026